Aller.o slashed.d, Denmark

Rolf Emil Amsler

This inventor holds 1 USPTO granted patent. Top assignee: Novo Nordisk A/s. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rolf Emil Amsler. Retrieved from https://idiyas.com/inventor/rolf-emil-amsler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rolf Emil Amsler: Innovator in Therapeutic Compounds

Introduction

Rolf Emil Amsler is a notable inventor based in Allerød, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic agents. His work has led to advancements that may benefit various medical applications.

Latest Patents

Rolf Emil Amsler holds a patent for "Acid addition salts of 2, 3, 4, 5-tetrahydro-1H-3-benzazepine compounds." This invention provides a series of crystalline salts of (S)-8-chloro-5-(5-bromo-2,3-dihydrobenzofuran-7-yl)-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7-ol. The preparation and use of these compounds as therapeutic agents represent a significant advancement in the field.

Career Highlights

Rolf Emil Amsler is associated with Novo Nordisk A/S, a leading global healthcare company. His role at the company has allowed him to focus on innovative solutions in the pharmaceutical industry. His expertise in medicinal chemistry has been instrumental in the development of new therapeutic agents.

Collaborations

Throughout his career, Rolf has collaborated with notable colleagues, including Louis B. Hansen and Scott E. McGraw. These collaborations have fostered an environment of innovation and have contributed to the success of various projects.

Conclusion

Rolf Emil Amsler's contributions to the field of medicinal chemistry and his innovative patent work highlight his importance as an inventor. His ongoing efforts in developing therapeutic agents continue to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…